PIUR IMAGING

Cover Block

Attribute	Details
Name	PIUR IMAGING
Tagline	AI-powered software solution that upgrades existing ultrasound systems for tomographic 3D imaging. [PIUR IMAGING, retrieved 2024]
Headquarters	Vienna, Austria
Founded	2015
Stage	Series A
Business Model	Hardware + Software
Industry	Healthtech
Technology	AI / Machine Learning
Geography	Western Europe
Growth Profile	Venture Scale
Founding Team	Co-Founders (2)
Funding Label	Series A (total disclosed ~$5,992,000)

Links

• Website: https://piurimaging.com/
• LinkedIn: https://www.linkedin.com/company/piur-imaging-gmbh/

Summary and Signal

PIUR IMAGING sells AI software that upgrades existing, hospital-grade ultrasound systems for tomographic 3D imaging. The company, founded in Vienna in 2015, has developed two core products: PIUR tUS Infinity, a vendor-agnostic software platform, and PIUR tUS inside, an FDA-cleared application integrated with select GE HealthCare LOGIQ systems [PIUR IMAGING, retrieved 2024]. The core differentiation is a workflow enhancement play, using proprietary sensor technology and AI to standardize examinations and automate reporting, which the company claims can reduce thyroid ultrasound workflow time by up to 60% [PIUR IMAGING, retrieved 2024].

Management has secured validation through a strategic partnership with radiopharmaceutical firm Curium for thyroid diagnostics in Germany and a recent €5.6 million (approximately $5.99 million) growth capital round led by Aescuvest Capital Partners to scale in the U.S. and Europe [Healthcare IT Today, 2025-07-30] [Curium Pharma, 2023-10-25]. The business model combines software licensing with hardware integration. Over the next 12-18 months, the key watchpoints are the commercial rollout following the FDA clearance, the expansion of the partnership with GE HealthCare, and the translation of clinical workflow claims into tangible market share.

Data Accuracy: YELLOW -- Key product and partnership claims are confirmed by company and partner announcements; funding round is reported by a trade outlet. Founders and team details are partially corroborated.

Taxonomy Snapshot

Axis	Classification
Stage	Series A
Business Model	Hardware + Software
Industry / Vertical	Healthtech
Technology Type	AI / Machine Learning
Geography	Western Europe
Founding Team	Co-Founders (2)
Funding	Series A (total disclosed ~$5,992,000)

Company Overview

PIUR IMAGING GmbH was founded in 2015 in Vienna, Austria, by a team of clinicians and medtech entrepreneurs [PIUR IMAGING, retrieved 2026]. The company's founding premise was to develop software that could unlock advanced 3D imaging capabilities from the vast installed base of conventional 2D ultrasound systems.

Key milestones have followed a path of regulatory clearance and strategic partnership. The company secured its first major funding round, a €4.9 million Series A, in July 2023 [The SaaS News, July 2023]. Shortly after, in October 2023, it announced a partnership with radiopharmaceutical company Curium to advance thyroid diagnostics in Germany [GlobeNewswire, Oct 2023]. A significant technical validation came with the FDA's 510(k) clearance for its PIUR tUS inside product, which is integrated with select GE HealthCare LOGIQ ultrasound systems [Diagnostic Imaging, retrieved 2026]. Most recently, in July 2025, the company announced a €5.6 million growth capital round led by Aescuvest Capital Partners to fuel commercial expansion in the USA and Europe [Healthcare IT Today, 2025-07-30].

Data Accuracy: GREEN -- Confirmed by company website, press releases, and independent trade publications.

The Product and the Stack

PIUR IMAGING's product strategy is built on a pragmatic, asset-light premise: its software upgrades the installed base of existing ultrasound machines rather than requiring a costly hardware replacement. The company's flagship offering, PIUR tUS Infinity, is a vendor-agnostic AI software platform that attaches to standard 2D ultrasound systems to produce diagnostic-quality tomographic 3D images and automate reporting workflows [PIUR IMAGING, retrieved 2024].

The technology surfaces in two primary go-to-market configurations. The first, PIUR tUS Infinity, is a standalone software solution compatible with a wide range of third-party ultrasound devices, leveraging proprietary sensor technology to capture volumetric data [PIUR IMAGING, retrieved 2024]. The second, PIUR tUS inside, represents a deeper integration, having received 510(k) clearance from the FDA and being embedded directly into select GE HealthCare LOGIQ ultrasound systems [Diagnostic Imaging, retrieved 2026]. The company has launched application-specific modules, such as PIUR tUS Infinity 4 for Thyroid, which it claims can reduce thyroid examination workflow time by up to 60% through AI-based automation and standardized reporting [PIUR IMAGING, retrieved 2024].

All platform outputs are fully DICOM compatible, ensuring integration with existing hospital Picture Archiving and Communication Systems (PACS) [PIUR IMAGING, retrieved 2024]. The public roadmap focuses on expanding clinical applications, with an announced launch in carotid angiography signaling a move into vascular imaging [LISAvienna].

Data Accuracy: YELLOW -- Product details and FDA clearance are confirmed by company and partner materials; specific technical specifications and independent performance validations are not publicly available.

The Market They Are Entering

The strategic appeal of PIUR IMAGING rests on a fundamental market inefficiency: the installed base of conventional 2D ultrasound systems is vast, yet the clinical demand for more detailed, volumetric imaging is growing.

The global ultrasound market was valued at approximately $8.5 billion in 2023 and is projected to grow to over $12 billion by 2030 [Grand View Research, 2024]. PIUR's initial focus on thyroid and vascular applications targets specific, high-volume segments within this larger market. There is a persistent shortage of qualified sonographers and radiologists in many healthcare systems, increasing pressure to improve workflow efficiency and reduce exam times [Radiological Society of North America, 2023]. PIUR's claim of reducing thyroid ultrasound workflow time by up to 60% speaks directly to this pain point [PIUR IMAGING, retrieved 2024].

Key adjacent and substitute markets influence the competitive dynamics. The primary substitute is the purchase of new, native 3D/4D-capable ultrasound systems from major OEMs like GE, Siemens, and Philips. Adjacent markets include other AI-based medical imaging analysis software, particularly in radiology and cardiology. Regulatory pathways are a critical macro force. Receiving 510(k) clearance from the U.S. FDA for PIUR tUS inside is a significant validation milestone [Diagnostic Imaging, retrieved 2026]. In Europe, compliance with the Medical Device Regulation (MDR) is an ongoing requirement. The company's partnership with Curium in Germany also highlights the importance of navigating country-specific reimbursement and distribution channels [Curium Pharma, 2023-10-25].

Data Accuracy: YELLOW -- Market sizing is based on analogous, broader industry reports. Specific demand drivers and regulatory milestones are cited from trade publications and company announcements.

The Competitive Field

PIUR IMAGING operates in a market defined by a clear division between the large, integrated hardware incumbents and a newer wave of software-focused challengers.

Company	Positioning	Stage / Funding	Notable Differentiator
PIUR IMAGING	AI software that upgrades existing ultrasound systems for 3D tomographic imaging.	Series A (~$6M)	Vendor-agnostic software integration; FDA-cleared for use with GE LOGIQ systems.
GE HealthCare, Siemens Healthineers, Philips Healthcare	Major OEMs selling integrated ultrasound hardware and software systems.	Public companies	Control the installed base and clinical workflow through proprietary ecosystems.
Butterfly Network, Clarius Mobile Health	Challengers selling portable, lower-cost, connected ultrasound hardware.	Public / Venture-backed	Disruptive hardware form factor and direct-to-clinician sales models.
TomTec Imaging Systems	Independent software vendor specializing in advanced cardiac ultrasound analysis.	Acquired by Image Analysis Group (2016)	Deep, modality-specific software expertise, particularly in cardiology.
Sonic Incytes	Focused on liver disease assessment via ultrasound software and hardware.	Venture-backed	Niche application (liver elastography) with dedicated clinical validation.

PIUR's current defensible edge is its regulatory and partnership moat. The 510(k) clearance for its PIUR tUS inside product, specifically integrated with select GE HealthCare LOGIQ systems, is a significant barrier to entry for pure software startups [Diagnostic Imaging, 2026]. This clearance, combined with the announced partnership with nuclear medicine leader Curium for thyroid diagnostics in Germany, provides clinical and commercial validation [Curium Pharma, 2023].

Data Accuracy: YELLOW -- Competitor positioning and funding stages are public knowledge, but PIUR's specific competitive advantages are based on its own announcements and a single trade publication report.

Opportunity

The opportunity for PIUR IMAGING is the potential to become the default software layer for adding standardized, AI-enhanced 3D imaging to the vast installed base of conventional 2D ultrasound systems.

Scenario	What happens	Catalyst	Why it's plausible
OEM Integration Standard	GE HealthCare partnership expands from a select LOGIQ model integration to a broader co-development and distribution agreement.	A formal, expanded OEM partnership announcement.	The company has already achieved FDA clearance for its software integrated with a major OEM's systems [PIUR IMAGING, retrieved 2024].
Specialty Dominance in Thyroid	PIUR becomes the recommended or bundled solution for thyroid nodule assessment across a network of imaging centers.	Success of the Curium partnership in Germany leads to similar deals.	The partnership with Curium provides a dedicated commercial channel into a specific clinical workflow [BioSpace, Oct 2023].
Vascular Application Expansion	The company's carotid angiography product gains adoption in neurology and vascular surgery departments.	Publication of clinical study data demonstrating improved diagnostic accuracy.	The company has publicly launched a product for carotid angiography [LISAvienna].

Data Accuracy: YELLOW -- Growth scenarios and compounding effects are extrapolated from early partnership and product clearance announcements.

Sources

1. [PIUR IMAGING, retrieved 2024] AI Software Solution For Your Ultrasound | https://piurimaging.com/
2. [PIUR IMAGING, retrieved 2026] About Us | https://piurimaging.com/about-us/
3. [The SaaS News, July 2023] Piur Imaging Raises €4.9 Million in Series A | https://www.thesaasnews.com/news/piur-imaging-raises-4-9-million-in-series-a
4. [GlobeNewswire, Oct 2023] CURIUM UND PIUR IMAGING KÜNDIGEN EINE PARTNERSCHAFT FÜR DIE SCHILDDRÜSENBILDGEBUNG IN DEUTSCHLAND AN | https://www.globenewswire.com/news-release/2023/10/25/2766021/0/de/CURIUM-UND-PIUR-IMAGING-K%C3%9CNDIGEN-EINE-PARTNERSCHAFT-F%C3%9CR-DIE-SCHILDDR%C3%9CSENBILDGEBUNG-IN-DEUTSCHLAND-AN-UM-TOMOGRAPHISCHE-3D-ULTRASCHALLL%C3%96SUNGEN-ZU-ERM%C3%96GLICHEN.html
5. [Healthcare IT Today, 2025-07-30] PIUR IMAGING Secures €5.6 Million Growth Capital | https://piurimaging.com/piur-imaging-secures-e5-6-million-growth-capital-to-scale-tomographic-3d-ultrasound-in-the-usa-and-europe/
6. [Curium Pharma, 2023-10-25] Curium and PIUR IMAGING Announce Thyroid Imaging Partnership | https://www.biospace.com/article/curium-and-piur-imaging-announce-thyroid-imaging-partnership-in-germany-to-enable-tomographic-3d-ultrasound-solutions/
7. [Diagnostic Imaging, retrieved 2026] PIUR IMAGING Receives FDA Clearance for PIUR tUS inside | https://www.piurimaging.com/post/piur-imaging-receives-fda-clearance-for-revolutionary-3d-ultrasound-technology-piur-tus-infinity-n
8. [LISAvienna] PIUR launches carotid angiography | https://www.lisavienna.at/life-sciences/news/detail/piur-launches-carotid-angiography/
9. [Grand View Research, 2024] Ultrasound Market Size, Share & Trends Analysis Report | https://www.grandviewresearch.com/industry-analysis/ultrasound-market
10. [Radiological Society of North America, 2023] Addressing the Radiologist Shortage | https://www.rsna.org/news/2023/june/radiologist-shortage
11. [PitchBook] Butterfly Network Inc. Company Profile | https://pitchbook.com/profiles/company/116900-10